ASO Author Reflections: Microsatellite and RAS/RAF Mutational Status as Prognostic Factors in Colorectal Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)

MeSH terms

• Antineoplastic Combined Chemotherapy Protocols / therapeutic use
• Colorectal Neoplasms* / drug therapy
• Colorectal Neoplasms* / therapy
• Combined Modality Therapy
• Cytoreduction Surgical Procedures
• Humans
• Hyperthermia, Induced*
• Hyperthermic Intraperitoneal Chemotherapy
• Microsatellite Repeats
• Peritoneal Neoplasms* / drug therapy
• Peritoneal Neoplasms* / therapy
• Prognosis
• Survival Rate